Clobazam Use in Epilepsia Partialis Continua - Pilot Study
Status:
Terminated
Trial end date:
2017-07-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate whether clobazam, brand name Onf®, is more effective
as an adjunctive or monotherapy in terminating Epilepsia Partialis Continua (EPC) than either
lorazepam and/or clonazepam.